Zynerba Pharma (ZYNE) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts ZYNE Hot Sheet
Join SI Premium – FREE
Zynerba Pharma (NASDAQ: ZYNE) reported Q3 EPS of ($0.67), $0.02 better than the analyst estimate of ($0.69).
For earnings history and earnings-related data on Zynerba Pharma (ZYNE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- SK hynix approves ₩40 trillion share buyback and cancellation plan
- Iridex Corp (IRIX) Misses Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
